Scope 2018

Strategikon launches Clinical Maestro: 50-75% of outsourcing process costs could be eliminated, says CEO

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Furtsef)
(Image: Getty/Furtsef)

Related tags: Management, Cost

Strategikon Pharma has released a new cloud-based solution to help plan, source, and manage clinical programs – with the goal of eliminating paper-based processes.

Clinical Maestro’s capabilities include modeling operational and cost scenarios, forecasting, selecting and managing clinical service providers and clinical contracts.

This is pioneering technology​,” said Anca Copaescu, Strategikon founder and CEO, last week at the SCOPE Summit in Orland, FL.

The platform covers the entire spectrum of planning, budgeting, and contract lifecycle management, she told us.

There are currently no commercial off-the-shelf solutions to automate outsourcing processes. The only tools available are customized, one-off solutions for big pharma. These are primarily bidding portals that are not connected to planning and budgeting and they are not available to the broader market,​” Copaescu said.

The platform features “dual applications​”– one that is sponsor facing and the other for contract research organizations (CROs).

Copaescu said the idea – and hope – is that the platform will be able to eliminate paper. “By paper, I mean the process of creating RFPs, using templates and responding in PDF, and managing excel budgets​,” she explained.

You can safely leave the excel and the paper and the template, and digitize core processes​,” she added, noting that the processes have historically been time-consuming and expensive for both sponsors and CROs.

There is so much potential to cut [costs],​” Copaescu said. “I am estimating between 50 and 75% of outsourcing process costs could be eliminated using Maestro​.”

“It’s really massive because you can create a plan in a minute. You can create an RFP in literally in the push of a button​,” she added. “It’s really dramatic and it’s beautiful too, and that’s why I’m so proud of it​.”

Related news

Show more

Related products

show more


Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...


Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Related suppliers